|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 5/0793 | (2010.01) |
| C12N 5/0797 | (2010.01) | ||
| A61K 35/30 | (2015.01) | ||
| A61P 27/02 | (2006.01) |
| (11) | Number of the document | 3189135 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15838263.0 |
| Date of filing the European patent application | 2015-09-05 | |
| (97) | Date of publication of the European application | 2017-07-12 |
| (45) | Date of publication and mention of the grant of the patent | 2021-06-02 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/048741 |
| Date | 2015-09-05 |
| (87) | Number | WO 2016/037159 |
| Date | 2016-03-10 |
| (30) | Number | Date | Country code |
| 201462046165 P | 2014-09-05 | US |
| (72) |
WANG, Wei , US
LU, Shi-Jiang , US
LANZA, Robert P. , US
|
| (73) |
Astellas Institute for Regenerative Medicine ,
9 Technology Drive, Westborough, MA 01581,
US
|
| (54) | RETINAL GANGLION CELLS AND PROGENITORS THEREOF |
| RETINAL GANGLION CELLS AND PROGENITORS THEREOF |